Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.

Sato Y, Iwamoto J, Kanoko T, Satoh K

Open source

DOI
10.1002/mds.20825
Published
2006 Jul
Container
Movement disorders : official journal of the Movement Disorder Society
Publisher
Not recorded
Open access
unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/mds.20825,
  title = {Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.},
  author = {Sato Y and Iwamoto J and Kanoko T and Satoh K},
  year = {2006},
  journal = {Movement disorders : official journal of the Movement Disorder Society},
  doi = {10.1002/mds.20825},
  url = {https://doi.org/10.1002/mds.20825}
}

RIS

TY  - JOUR
TI  - Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.
AU  - Sato Y
AU  - Iwamoto J
AU  - Kanoko T
AU  - Satoh K
PY  - 2006
JO  - Movement disorders : official journal of the Movement Disorder Society
DO  - 10.1002/mds.20825
UR  - https://doi.org/10.1002/mds.20825
ER  - 

APA

Y, S., J, I., T, K., & K, S. (2006). Alendronate and vitamin D2 for prevention of hip fracture in Parkinson's disease: a randomized controlled trial.. Movement disorders : official journal of the Movement Disorder Society. https://doi.org/10.1002/mds.20825

Source records